Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1979 1
1980 1
1982 4
1983 1
1987 2
1988 1
1989 2
1990 2
1991 2
1992 4
1994 1
1995 2
1996 1
1998 2
1999 3
2000 3
2001 3
2002 7
2003 7
2004 10
2005 10
2006 7
2007 8
2008 18
2009 18
2010 28
2011 22
2012 19
2013 14
2014 17
2015 12
2016 14
2017 12
2018 12
2019 12
2020 18
2021 15
2022 15
2023 12
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

307 results

Results by year

Filters applied: . Clear all
Page 1
TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory.
Ausejo-Mauleon I, Labiano S, de la Nava D, Laspidea V, Zalacain M, Marrodán L, García-Moure M, González-Huarriz M, Hervás-Corpión I, Dhandapani L, Vicent S, Collantes M, Peñuelas I, Becher OJ, Filbin MG, Jiang L, Labelle J, de Biagi-Junior CAO, Nazarian J, Laternser S, Phoenix TN, van der Lugt J, Kranendonk M, Hoogendijk R, Mueller S, De Andrea C, Anderson AC, Guruceaga E, Koschmann C, Yadav VN, Gállego Pérez-Larraya J, Patiño-García A, Pastor F, Alonso MM. Ausejo-Mauleon I, et al. Among authors: pastor f. Cancer Cell. 2023 Nov 13;41(11):1911-1926.e8. doi: 10.1016/j.ccell.2023.09.001. Epub 2023 Oct 5. Cancer Cell. 2023. PMID: 37802053 Free PMC article.
Performance Determinants in Trail-Running Races of Different Distances.
Pastor FS, Besson T, Varesco G, Parent A, Fanget M, Koral J, Foschia C, Rupp T, Rimaud D, Féasson L, Millet GY. Pastor FS, et al. Int J Sports Physiol Perform. 2022 Jun 1;17(6):844-851. doi: 10.1123/ijspp.2021-0362. Epub 2022 Feb 25. Int J Sports Physiol Perform. 2022. PMID: 35213820
Modulating T Cell Responses by Targeting CD3.
Menon AP, Moreno B, Meraviglia-Crivelli D, Nonatelli F, Villanueva H, Barainka M, Zheleva A, van Santen HM, Pastor F. Menon AP, et al. Among authors: pastor f. Cancers (Basel). 2023 Feb 13;15(4):1189. doi: 10.3390/cancers15041189. Cancers (Basel). 2023. PMID: 36831533 Free PMC article. Review.
Oligonucleotide-Based Therapies for Renal Diseases.
Cartón-García F, Saande CJ, Meraviglia-Crivelli D, Aldabe R, Pastor F. Cartón-García F, et al. Among authors: pastor f. Biomedicines. 2021 Mar 16;9(3):303. doi: 10.3390/biomedicines9030303. Biomedicines. 2021. PMID: 33809425 Free PMC article. Review.
An RNA toolbox for cancer immunotherapy.
Pastor F, Berraondo P, Etxeberria I, Frederick J, Sahin U, Gilboa E, Melero I. Pastor F, et al. Nat Rev Drug Discov. 2018 Oct;17(10):751-767. doi: 10.1038/nrd.2018.132. Epub 2018 Sep 7. Nat Rev Drug Discov. 2018. PMID: 30190565 Review.
Aptamer-iRNAs as Therapeutics for Cancer Treatment.
Soldevilla MM, Meraviglia-Crivelli de Caso D, Menon AP, Pastor F. Soldevilla MM, et al. Among authors: pastor f. Pharmaceuticals (Basel). 2018 Oct 18;11(4):108. doi: 10.3390/ph11040108. Pharmaceuticals (Basel). 2018. PMID: 30340426 Free PMC article. Review.
Aptamers: A Feasible Technology in Cancer Immunotherapy.
Soldevilla MM, Villanueva H, Pastor F. Soldevilla MM, et al. Among authors: pastor f. J Immunol Res. 2016;2016:1083738. doi: 10.1155/2016/1083738. Epub 2016 Jun 20. J Immunol Res. 2016. PMID: 27413756 Free PMC article. Review.
Current management of uterine sarcomas.
García-Martínez E, Egea Prefasi L, García-Donas J, Escolar-Pérez PP, Pastor F, González-Martín A. García-Martínez E, et al. Among authors: pastor f. Clin Transl Oncol. 2011 May;13(5):307-14. doi: 10.1007/s12094-011-0659-0. Clin Transl Oncol. 2011. PMID: 21596658 Review.
Idiotype vaccines for lymphoma therapy.
Inogés S, de Cerio AL, Villanueva H, Soria E, Pastor F, Bendandi M. Inogés S, et al. Among authors: pastor f. Expert Rev Vaccines. 2011 Jun;10(6):801-9. doi: 10.1586/erv.11.44. Expert Rev Vaccines. 2011. PMID: 21692701 Review.
307 results